Parkinson disease: Poor results for retinal cell transplants in Parkinson disease

Nature Reviews Neurology

Volumn 7, Issue 8, 2011, Pages 424-425

  Cenci, M Angela ^a   Widner, Håkan ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE; LEVODOPA;

CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; DOPAMINE RELEASE; HUMAN; INTERMETHOD COMPARISON; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATIENT SAFETY; PHYSICAL TOLERANCE; PIGMENT EPITHELIUM; PLACEBO EFFECT; PRIORITY JOURNAL; RETINA CELL; REVIEW; SHAM PROCEDURE; THERAPY EFFECT; TREATMENT PLANNING;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS, PHASE II AS TOPIC; HAPLORHINI; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINAL PIGMENT EPITHELIUM; TREATMENT OUTCOME;

EID: 80051548106     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.111     Document Type: Review

References (8)

1. Gross, R. E. et al. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: A double-blind, randomised, controlled trial. Lancet Neurol. 10, 509-519 (2011).
2. Flores, J. et al. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease. J. Neuropathol. Exp. Neurol. 66, 585-596 (2007). (Pubitemid 47051704)
3. Subramanian, T. et al. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant. 11, 207-214 (2002). (Pubitemid 34665821)
4. Stover, N. P. et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch. Neurol. 62, 1833-1837 (2005). (Pubitemid 41785076)
5. Goetz, C. G. et al. Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Mov. Disord. 23, 690-699 (2008).
6. Cenci, M. A. et al. Animal models of neurological deficits: How relevant is the rat? Nat. Rev. Neurosci. 3, 574-579 (2002). (Pubitemid 135706667)
7. Doudet, D. J. et al. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp. Neurol. 189, 361-368 (2004). (Pubitemid 39221828)
8. Cepeda, I. L. et al. Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease. J. Neuropathol. Exp. Neurol. 66, 576-584 (2007). (Pubitemid 47051703)